Hedges Asset Management’s Wabtec WAB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$270K Buy
+1,000
New +$264K 0.18% 99
2025
Q4
$331K Sell
1,550
-100
-6% -$20.5K 0.23% 88
2025
Q3
$331K Hold
1,650
0.25% 81
2025
Q2
$345K Hold
1,650
0.28% 82
2025
Q1
$299K Hold
1,650
0.2% 93
2024
Q4
$313K Hold
1,650
0.21% 91
2024
Q3
$300K Hold
1,650
0.2% 92
2024
Q2
$261K Sell
1,650
-850
-34% -$136K 0.19% 95
2024
Q1
$364K Sell
2,500
-50
-2% -$6.77K 0.26% 81
2023
Q4
$324K Sell
2,550
-50
-2% -$5.64K 0.25% 84
2023
Q3
$276K Hold
2,600
0.24% 85
2023
Q2
$285K Hold
2,600
0.24% 88
2023
Q1
$263K Sell
2,600
-150
-5% -$15.3K 0.22% 89
2022
Q4
$274K Hold
2,750
0.25% 84
2022
Q3
$224K Sell
2,750
-300
-10% -$26.5K 0.22% 87
2022
Q2
$250K Sell
3,050
-100
-3% -$8.91K 0.24% 86
2022
Q1
$303K Hold
3,150
0.23% 93
2021
Q4
$290K Buy
+3,150
New +$289K 0.23% 97

Other funds holding WAB

Hedges Asset Management's WAB Position: Q2 2026 in Review

Hedges Asset Management opened a new position in Wabtec (WAB) in Q2 2026: 1,000 shares worth $270K. The stake represents 0.18% of the portfolio and ranks #99 among its holdings. This is a return to the name: Hedges Asset Management previously reported a position in WAB as recently as Q4 2025.

Hedges Asset Management first reported a position in WAB in Q4 2021 and has held it in 18 quarters since. The position peaked at $364K in Q1 2024. 1,187 funds tracked by Wall St. Rank hold WAB as of Q2 2026.

  • Hedges Asset Management held 1,000 shares of Wabtec worth $270K as of Q2 2026.
  • Wabtec was a new Hedges Asset Management position in Q2 2026.
  • Wabtec made up 0.18% of Hedges Asset Management's portfolio in Q2 2026, its #99 holding.
  • Hedges Asset Management first reported a position in Wabtec in Q4 2021 and has held it in 18 quarters since.
  • Hedges Asset Management's Wabtec position peaked at $364K in Q1 2024.
  • 1,187 funds tracked by Wall St. Rank held Wabtec as of Q2 2026.

Based on Hedges Asset Management's 13F filing for Q2 2026, filed 27 Jul 2026.